MCID: ANT011
MIFTS: 50

Antisocial Personality Disorder

Categories: Mental diseases

Aliases & Classifications for Antisocial Personality Disorder

MalaCards integrated aliases for Antisocial Personality Disorder:

Name: Antisocial Personality Disorder 12 76 55 44 15 73
Psychopathic Personality Disorder 12
Dissocial Personality Disorder 12
Psychopathic Personality 12
Sociopathic Personality 12
Psychopath.personality 12
Asocial Personality 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10939
ICD10 33 F60.2
ICD9CM 35 301.7
MeSH 44 D000987
NCIt 50 C88413
UMLS 73 C0003431

Summaries for Antisocial Personality Disorder

Disease Ontology : 12 A personality disorder that involves a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood.

MalaCards based summary : Antisocial Personality Disorder, also known as psychopathic personality disorder, is related to impulse control disorder and cocaine dependence. An important gene associated with Antisocial Personality Disorder is MAOA (Monoamine Oxidase A), and among its related pathways/superpathways are Circadian entrainment and Transmission across Chemical Synapses. The drugs Naratriptan and Sumatriptan have been mentioned in the context of this disorder. Affiliated tissues include cortex, prefrontal cortex and brain, and related phenotypes are behavior/neurological and homeostasis/metabolism

Wikipedia : 76 Antisocial personality disorder (ASPD or APD) is a personality disorder characterized by a long term... more...

Related Diseases for Antisocial Personality Disorder

Diseases related to Antisocial Personality Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 90)
# Related Disease Score Top Affiliating Genes
1 impulse control disorder 32.1 ANKK1 DRD2
2 cocaine dependence 30.9 DRD2 SLC6A3 SLC6A4
3 heroin dependence 30.9 ANKK1 DRD2
4 generalized anxiety disorder 30.5 DRD2 MAOA SLC6A4
5 cocaine abuse 30.2 DRD2 SLC6A3 SLC6A4
6 anxiety 30.1 COMT MAOA SLC6A4
7 conduct disorder 30.0 ALDH2 COMT DRD2 MAOA SLC6A3 SLC6A4
8 drug dependence 30.0 ANKK1 DRD2 SLC6A4
9 substance dependence 29.5 DRD2 HTR1B MAOA SLC6A3 SLC6A4
10 alcohol abuse 29.5 ALDH2 ANKK1 DRD2 SLC6A4
11 borderline personality disorder 29.3 COMT HTR1B MAOA SLC6A4
12 pathological gambling 28.9 DRD2 MAOA MAOB SLC6A3 SLC6A4
13 alexithymia 28.7 ANKK1 COMT DRD2 SLC6A4
14 bulimia nervosa 28.6 COMT HTR1B MAOA SLC6A4
15 bipolar disorder 28.5 COMT DRD2 MAOA SLC6A3 SLC6A4
16 substance abuse 28.4 COMT DRD2 HTR1B MAOA SLC6A3 SLC6A4
17 disease of mental health 28.2 ALDH2 COMT DRD2 MAOA SLC6A3 SLC6A4
18 personality disorder 27.7 ALDH2 COMT DRD2 HTR1B MAOA MAOB
19 schizophrenia 26.3 COMT DRD2 HTR1B MAOA MAOB SLC6A3
20 alcohol dependence 25.7 ALDH2 ANKK1 COMT DRD2 HTR1B MAOA
21 attention deficit-hyperactivity disorder 24.9 ANKK1 COMT DRD2 HTR1B MAOA MAOB
22 dysthymic disorder 10.7 MAOA SLC6A4
23 kleptomania 10.7 MAOA SLC6A4
24 agoraphobia 10.6 MAOA SLC6A4
25 periodic limb movement disorder 10.5 DRD2 SLC6A4
26 striatonigral degeneration 10.5 DRD2 SLC6A3
27 bruxism 10.5 DRD2 SLC6A4
28 tic disorder 10.5 DRD2 SLC6A3
29 taqi polymorphism 10.4 ANKK1 DRD2
30 endogenous depression 10.4 MAOA SLC6A4
31 depression 10.3
32 social phobia 10.3 DRD2 MAOA SLC6A4
33 migraine without aura 10.3 DRD2 SLC6A4
34 exhibitionism 10.3 MAOA MAOB
35 alcohol-induced mental disorder 10.3 DRD2 SLC6A3 SLC6A4
36 alcoholic psychosis 10.3 DRD2 SLC6A3 SLC6A4
37 dependent personality disorder 10.3 MAOA MAOB
38 opiate dependence 10.2 DRD2 SLC6A4
39 paraphilia disorder 10.1 MAOA MAOB
40 pure autonomic failure 10.1 MAOA MAOB
41 phobia, specific 10.1 COMT MAOA
42 atypical depressive disorder 10.1 MAOA MAOB SLC6A4
43 serotonin syndrome 10.0 MAOA MAOB SLC6A4
44 sexual sadism 10.0
45 somatization disorder 10.0
46 schizophreniform disorder 10.0 COMT DRD2
47 polysubstance abuse 10.0 COMT DRD2
48 tardive dyskinesia 10.0 COMT DRD2
49 fibromyalgia 9.9 COMT SLC6A4
50 cognitive function 1, social 9.9

Comorbidity relations with Antisocial Personality Disorder via Phenotypic Disease Network (PDN):


Schizophreniform Disorder

Graphical network of the top 20 diseases related to Antisocial Personality Disorder:



Diseases related to Antisocial Personality Disorder

Symptoms & Phenotypes for Antisocial Personality Disorder

MGI Mouse Phenotypes related to Antisocial Personality Disorder:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.1 MAOA MAOB SLC6A3 SLC6A4 SNAP25 ALDH2
2 homeostasis/metabolism MP:0005376 9.97 ALDH2 COL25A1 COMT DRD2 MAOA MAOB
3 endocrine/exocrine gland MP:0005379 9.91 SLC6A4 SNAP25 ALDH2 COMT DRD2 HTR1B
4 nervous system MP:0003631 9.81 ALDH2 COL25A1 COMT DRD2 MAOA MAOB
5 muscle MP:0005369 9.73 COL25A1 DRD2 HTR1B SLC6A3 SLC6A4 SNAP25
6 reproductive system MP:0005389 9.43 ALDH2 COMT DRD2 HTR1B SLC6A3 SNAP25
7 taste/olfaction MP:0005394 8.8 DRD2 SLC6A3 SNAP25

Drugs & Therapeutics for Antisocial Personality Disorder

Drugs for Antisocial Personality Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 33)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Naratriptan Approved, Investigational Phase 4 143388-64-1, 121679-13-8 4440
2
Sumatriptan Approved, Investigational Phase 4 103628-46-2 5358
3 Neurotransmitter Agents Phase 4
4 Vasoconstrictor Agents Phase 4,Phase 1
5 Serotonin 5-HT1 Receptor Agonists Phase 4
6 Serotonin Agents Phase 4
7
Serotonin Investigational, Nutraceutical Phase 4 50-67-9 5202
8 Antioxidants Phase 2, Phase 3
9 Omega 3 Fatty Acid Nutraceutical Phase 2, Phase 3,Phase 3
10 Pomegranate Nutraceutical Phase 2, Phase 3
11 Arginine Vasopressin Phase 1
12 Coagulants Phase 1
13 Hemostatics Phase 1
14 Natriuretic Agents Phase 1
15 Vasopressins Phase 1
16 arginine Nutraceutical Phase 1
17
Guanfacine Approved, Investigational 29110-47-2 3519
18
Norepinephrine Approved 51-41-2 439260
19
Yohimbine Approved, Investigational, Vet_approved 146-48-5 8969
20
Dopamine Approved 51-61-6, 62-31-7 681
21
Ethanol Approved Not Applicable 64-17-5 702
22
Morphine Approved, Investigational Not Applicable 57-27-2 5288826
23 Adrenergic Agents
24 Adrenergic Agonists
25 Adrenergic alpha-Agonists
26 Autonomic Agents
27 Peripheral Nervous System Agents
28 Central Nervous System Stimulants
29 Dopamine Agents
30 Dopamine Uptake Inhibitors
31 Lisdexamfetamine Dimesylate
32 Neurotransmitter Uptake Inhibitors
33 Yohimbe Nutraceutical

Interventional clinical trials:

(show all 33)
# Name Status NCT ID Phase Drugs
1 Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) Completed NCT00000388 Phase 4 Anti-ADHD medication
2 Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order Terminated NCT00282165 Phase 4 naratriptan;placebo
3 Omega-3 Supplementation and Behavior Problems Unknown status NCT02334098 Phase 2, Phase 3
4 Effect of Omega-3 Supplementation on Child Behavior Problems Completed NCT02016079 Phase 2, Phase 3
5 Working Memory Training in Adults With Substance Abuse and Executive Function Deficits. Unknown status NCT02068261 Phase 2
6 The Impact of Psychopathic Traits on the Efficacy of a Substance Use Intervention Completed NCT01532934 Phase 2
7 Neurological Influences on Drug Prevention Intervention Completed NCT00198939 Phase 1, Phase 2
8 Youth Drug Abuse Family and Cognitive-Behavioral Therapy Completed NCT00198874 Phase 2
9 Vasopressin Effects on Human Social Communication Completed NCT01327027 Phase 1 Vasopressin, Arginine, ADH;Placebo; Sterile Saline
10 Antisocial Behavior: Passing From Parent to Child to Grandchild Unknown status NCT00060788
11 Mental Health Related to School Dropout in Luxembourg Unknown status NCT01354236
12 Conduct Disorder in Prison: Search for Prospective and Retrospective Recurring and Contextual Elements Completed NCT02493088
13 Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates Completed NCT01428349 Not Applicable
14 Impaired Decision-making in Adolescents Completed NCT01253993
15 The Role of Norepinephrine in Emotional Processing Completed NCT00109642
16 Psychological Mechanisms of Behavioral Dysregulation Completed NCT00352456
17 Early Exposure to Lead and Adult Antisocial Outcomes Completed NCT00285610
18 To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder Completed NCT01263548 lisdexamfetamine dimesylate
19 Effectiveness of a Cognitive-behavioral Program of Coping With Psychological Stress in People With Retinitis Pigmentosa Completed NCT03368027 Not Applicable
20 European Comparative Effectiveness Research on Internet-based Depression Treatment Completed NCT02542891 Not Applicable
21 Justice-Involved Veterans and Moral Reconation Therapy Recruiting NCT02524171 Not Applicable
22 Emotion Recognition Training in Antisocial Violent Offenders With Psychopathic Traits Recruiting NCT03382808 Not Applicable
23 An 18-Month Psychotherapy of Borderline Personality Disorder Recruiting NCT03329677 Not Applicable
24 Multisystemic Therapy-Emerging Adults (MST-EA) for Substance Abuse Recruiting NCT03035877 Not Applicable
25 Multisystemic Therapy-Emerging Adults Trial Recruiting NCT02922335 Not Applicable
26 Treating Co-Occurring Substance Use and Mental Disorders Among Jail Inmates Recruiting NCT02214667 Not Applicable
27 Improving Emotion Regulation Skills Among Adolescents Attempting to Lose Weight Recruiting NCT03393221 Not Applicable
28 Mentalization-based Training for Adolescents With Conduct Disorder (MBT-CD) Recruiting NCT02988453 Not Applicable
29 The Effect of Repeated Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior Active, not recruiting NCT02674516 Not Applicable
30 The Effect of Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior Active, not recruiting NCT02427672 Not Applicable
31 Multisite Prevention of Conduct Problems (Fast Track) Active, not recruiting NCT01653535 Not Applicable
32 Psychobiological Effects of Meditation on Offenders With Psychopathy Not yet recruiting NCT02894203 Not Applicable
33 Role of Oxytocin in Telling and Detecting Lies Withdrawn NCT02361177 Early Phase 1 Oxytocin

Search NIH Clinical Center for Antisocial Personality Disorder

Cochrane evidence based reviews: antisocial personality disorder

Genetic Tests for Antisocial Personality Disorder

Anatomical Context for Antisocial Personality Disorder

MalaCards organs/tissues related to Antisocial Personality Disorder:

41
Cortex, Prefrontal Cortex, Brain, Testes, Amygdala, Thyroid, Eye

Publications for Antisocial Personality Disorder

Articles related to Antisocial Personality Disorder:

(show top 50) (show all 384)
# Title Authors Year
1
Episodic memory and consciousness in antisocial personality disorder and conduct disorder. ( 29353574 )
2018
2
The Endocannabinoid System, Aggression, and the Violence of Synthetic Cannabinoid Use, Borderline Personality Disorder, Antisocial Personality Disorder, and Other Psychiatric Disorders. ( 29636670 )
2018
3
Movies in Mind: 'We need to talk about Kevin'-Is an antisocial personality disorder 'born' or 'made'? ( 29676160 )
2018
4
The effects of working memory load and attention refocusing on delay discounting rates in alcohol use disorder with comorbid antisocial personality disorder. ( 29277285 )
2018
5
Corticostriatal Connectivity in Antisocial Personality Disorder by MAO-A Genotype and Its Relationship to Aggressive Behavior. ( 29746646 )
2018
6
Changes in Resting EEG in Colombian Ex-combatants ith Antisocial Personality Disorder. ( 29754711 )
2018
7
Treatment of antisocial personality disorder: Development of a practice focused framework. ( 29853015 )
2018
8
Reduced White Matter Integrity in Antisocial Personality Disorder: A Diffusion Tensor Imaging Study. ( 28223713 )
2017
9
Association of monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder and high psychopathic traits. ( 28851912 )
2017
10
Orbito-frontal cortex volumes in patients with antisocial personality disorder. ( 28784365 )
2017
11
A prospective, longitudinal, study of men with borderline personality disorder with and without comorbid antisocial personality disorder. ( 29225887 )
2017
12
A Psychometric Evaluation of the DSM-IV Criteria for Antisocial Personality Disorder: Dimensionality, Local Reliability, and Differential Item Functioning Across Gender. ( 29284276 )
2017
13
Oxytocin improves facial emotion recognition in young adults with antisocial personality disorder. ( 28865940 )
2017
14
More inflammation but less brain-derived neurotrophic factor in antisocial personality disorder. ( 28810156 )
2017
15
Neuropsychology and emotion processing in violent individuals with antisocial personality disorder or schizophrenia: The same or different? A systematic review and meta-analysis. ( 28992741 )
2017
16
Neural Mechanisms Underlying Affective Theory of Mind in Violent Antisocial Personality Disorder and/or Schizophrenia. ( 28199713 )
2017
17
Did you get any help? A post-hoc secondary analysis of a randomized controlled trial of psychoeducation for patients with antisocial personality disorder in outpatient substance abuse treatment programs. ( 28068951 )
2017
18
Neurocognitive dysfunction in problem gamblers with co-occurring antisocial personality disorder. ( 28528231 )
2017
19
Antisocial Personality Disorder in Older Adults: A Critical Review. ( 28954596 )
2017
20
Genetic and Environmental Structure of DSM-IV Criteria for Antisocial Personality Disorder: A Twin Study. ( 28108863 )
2017
21
Offenders With Antisocial Personality Disorder Display More Impairments in Mentalizing. ( 27064853 )
2016
22
Evidence for an agitated-aggressive syndrome in early-onset psychosis correlated with antisocial personality disorder, forensic history, and substance use disorder. ( 27117676 )
2016
23
Experiential avoidance, empathy, and anger-related attitudesin antisocial personality disorder. ( 28081330 )
2016
24
Examining the DSM-5 Alternative Personality Disorder Model Operationalization of Antisocial Personality Disorder and Psychopathy in a Male Correctional Sample. ( 26914324 )
2016
25
Heightened early-attentional stimulus orienting and impulsive action in men with antisocial personality disorder. ( 27662886 )
2016
26
Clinical differences between cocaine-dependent patients with and without antisocial personality disorder. ( 27839828 )
2016
27
The Relationship between Aggression and Serum Thyroid Hormone Level in Individuals Diagnosed with Antisocial Personality Disorder. ( 28360783 )
2016
28
Individual and Network Correlates of Antisocial Personality Disorder Among Rural Nonmedical Prescription Opioid Users. ( 27171488 )
2016
29
Neurocognitive Deficits Associated with Antisocial Personality Disorder in Non-treatment-seeking Young Adults. ( 27236178 )
2016
30
Genome-wide association study of antisocial personality disorder. ( 27598967 )
2016
31
Disrupted functional connectome in antisocial personality disorder. ( 27541949 )
2016
32
A randomised controlled trial of mentalization-based treatment versus structured clinical management for patients with comorbid borderline personality disorder and antisocial personality disorder. ( 27577562 )
2016
33
Association of ventral striatum monoamine oxidase-A binding and functional connectivity in antisocial personality disorder with high impulsivity: A positron emission tomography and functional magnetic resonance imaging study. ( 26908392 )
2016
34
Comorbid trajectories of substance use as predictors of Antisocial Personality Disorder, Major Depressive Episode, and Generalized Anxiety Disorder. ( 27344118 )
2016
35
Reduced cortical thickness and increased surface area in antisocial personality disorder. ( 27600947 )
2016
36
Aberrant functional brain connectome in people with antisocial personality disorder. ( 27257047 )
2016
37
An Adverse Family Environment During Adolescence Predicts Marijuana Use and Antisocial Personality Disorder in Adulthood. ( 27034610 )
2016
38
Psychopathy, Antisocial Personality Disorder, and Reconviction in an Australian Sample of Forensic Patients. ( 27288398 )
2016
39
Facial emotion perception impairments in schizophrenia patients with comorbid antisocial personality disorder. ( 26778631 )
2016
40
Modulatory effects of psychopathy on Wisconsin Card Sorting Test performance in male offenders with Antisocial Personality Disorder. ( 26708441 )
2016
41
Impulsive lifestyle counseling to prevent dropout from treatment for substance use disorders in people with antisocial personality disorder: A randomized study. ( 26882500 )
2016
42
Neural Substrates of Antisocial Personality Disorder: Current State and Future Directions. ( 27776462 )
2016
43
The Natural History of Antisocial Personality Disorder. ( 26175389 )
2015
44
Lifetime trauma victimization and PTSD in relation to psychopathy and antisocial personality disorder in a sample of incarcerated women and men. ( 26062658 )
2015
45
"They're Really PD Today": An Exploration of Mental Health Nursing Students' Perceptions of Developing a Therapeutic Relationship With Patients With a Diagnosis of Antisocial Personality Disorder. ( 26169569 )
2015
46
Co-occurring mental illness, substance use disorders, and antisocial personality disorder among clients of forensic mental health services. ( 25799303 )
2015
47
Gender differences in the clinical characteristics and psychiatric comorbidity in patients with antisocial personality disorder. ( 26296756 )
2015
48
Epidemiology, Comorbidity, and Behavioral Genetics of Antisocial Personality Disorder and Psychopathy. ( 26594067 )
2015
49
Psycho-education for substance use and antisocial personality disorder: a randomized trial. ( 26573140 )
2015
50
Antisocial Personality Disorder and Pathological Narcissism in Prolonged Conflicts and Wars of the 21st Century. ( 26456397 )
2015

Variations for Antisocial Personality Disorder

Expression for Antisocial Personality Disorder

Search GEO for disease gene expression data for Antisocial Personality Disorder.

Pathways for Antisocial Personality Disorder

Pathways related to Antisocial Personality Disorder according to GeneCards Suite gene sharing:

(show all 17)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.79 COMT DRD2 MAOA MAOB SLC6A3
2
Show member pathways
12.74 ALDH2 COMT MAOA SLC6A3 SLC6A4 SNAP25
3
Show member pathways
11.98 ALDH2 MAOA MAOB
4 11.94 MAOA SLC6A4 SNAP25
5
Show member pathways
11.74 DRD2 MAOA MAOB SLC6A3
6 11.68 HTR1B MAOA MAOB SLC6A4
7
Show member pathways
11.57 COMT MAOA MAOB
8
Show member pathways
11.43 ALDH2 MAOA MAOB
9
Show member pathways
11.29 MAOA SLC6A3 SLC6A4
10
Show member pathways
11.16 ALDH2 MAOA MAOB
11 11.07 MAOB SLC6A3
12 11.06 HTR1B MAOA SLC6A4
13
Show member pathways
10.88 COMT MAOA
14 10.58 COMT MAOA MAOB
15
Show member pathways
10.45 ALDH2 MAOA MAOB
16
Show member pathways
10.44 ALDH2 COMT MAOA SLC6A3 SLC6A4
17
Show member pathways
10.43 ALDH2 COMT MAOA MAOB

GO Terms for Antisocial Personality Disorder

Cellular components related to Antisocial Personality Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 axon GO:0030424 8.92 COMT DRD2 SLC6A3 SNAP25

Biological processes related to Antisocial Personality Disorder according to GeneCards Suite gene sharing:

(show all 25)
# Name GO ID Score Top Affiliating Genes
1 response to toxic substance GO:0009636 9.69 DRD2 MAOB SLC6A4
2 locomotory behavior GO:0007626 9.65 DRD2 SLC6A3 SNAP25
3 neurotransmitter transport GO:0006836 9.62 SLC6A3 SLC6A4
4 feeding behavior GO:0007631 9.62 DRD2 HTR1B
5 response to nicotine GO:0035094 9.61 DRD2 SLC6A3
6 positive regulation of multicellular organism growth GO:0040018 9.61 DRD2 SLC6A3
7 associative learning GO:0008306 9.6 DRD2 SNAP25
8 regulation of dopamine secretion GO:0014059 9.59 DRD2 HTR1B
9 response to iron ion GO:0010039 9.58 DRD2 SLC6A3
10 vasoconstriction GO:0042310 9.58 HTR1B SLC6A4
11 negative regulation of synaptic transmission, glutamatergic GO:0051967 9.57 DRD2 HTR1B
12 dopamine metabolic process GO:0042417 9.56 COMT DRD2
13 response to ethanol GO:0045471 9.56 DRD2 HTR1B MAOB SLC6A3
14 neurotransmitter biosynthetic process GO:0042136 9.55 SLC6A3 SLC6A4
15 prepulse inhibition GO:0060134 9.54 DRD2 SLC6A3
16 G-protein coupled receptor internalization GO:0002031 9.52 DRD2 HTR1B
17 response to cocaine GO:0042220 9.5 DRD2 HTR1B SLC6A3
18 catecholamine metabolic process GO:0006584 9.49 COMT MAOA
19 monoamine transport GO:0015844 9.46 SLC6A3 SLC6A4
20 adenohypophysis development GO:0021984 9.43 DRD2 SLC6A3
21 response to drug GO:0042493 9.43 COMT DRD2 HTR1B MAOB SLC6A3 SLC6A4
22 dopamine uptake involved in synaptic transmission GO:0051583 9.4 SLC6A3 SLC6A4
23 negative regulation of serotonin secretion GO:0014063 9.37 HTR1B MAOB
24 neurotransmitter catabolic process GO:0042135 9.33 COMT MAOA MAOB
25 dopamine catabolic process GO:0042420 8.92 COMT MAOA MAOB SLC6A3

Molecular functions related to Antisocial Personality Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 syntaxin-1 binding GO:0017075 9.4 SLC6A4 SNAP25
2 neurotransmitter:sodium symporter activity GO:0005328 9.37 SLC6A3 SLC6A4
3 drug binding GO:0008144 9.33 DRD2 HTR1B SLC6A3
4 dopamine binding GO:0035240 9.32 DRD2 SLC6A3
5 monoamine transmembrane transporter activity GO:0008504 9.26 SLC6A3 SLC6A4
6 primary amine oxidase activity GO:0008131 8.96 MAOA MAOB
7 dopamine:sodium symporter activity GO:0005330 8.62 SLC6A3 SLC6A4

Sources for Antisocial Personality Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....